PUBLISHER: GlobalData | PRODUCT CODE: 1410886
PUBLISHER: GlobalData | PRODUCT CODE: 1410886
Stone Management Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Nephrology and Urology Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Stone Management Disposables market for the year 2020 and beyond.
Nephrolithiasis:
Nephrolithiasis, or kidney stone disease, is a condition in which individuals form stones in the kidney or urinary tract. Kidney stones are a common cause of blood in the urine and pain in the abdomen, flank, or groin. The incidence of the disease is increasing yearly due to changing climatic, geographical conditions, genetic factors and eating habits. Occurrence of kidney stone is more common in men in comparison with women.
Kidney stones can be classified based on their chemical composition: calcium oxalate, calcium phosphate, uric acid, cysteine, struvite. Calcium oxalate stones are the most commonly formed stones and account for approximately 82% of stone cases.
Management of the stones involves close monitoring of patients with use of different combination of drugs or surgical interventions. Surgical management includes ureteroscopy (URS), shock wave lithotripsy (SWL) and percutaneous nephrolithotomy (PCNL).
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Stone Management Disposables and evolving competitive landscape:
2015- 2033.
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, Cook Group Inc, Olympus Corp, Becton Dickinson and Co, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable